1815-PUB: Overactive Bladder Syndrome—An Emerging Complication of SGLT2 Inhibitor–Associated Urogenital Infections
Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 [Peer Reviewed Journal]Copyright American Diabetes Association Jun 2023 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db23-1815-PUB
Digital Resources/Online E-Resources